Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.
Bright Minds Biosciences has raised $175.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Bright Minds Biosciences's investors include PsyMed Ventures.
Bright Minds Biosciences is headquartered in Vancouver, Canada.
Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.
Bright Minds Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bright Minds Biosciences — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/bright-minds-biosciences. Accessed August 13, 2026.
VCBacked. (2026). Bright Minds Biosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/bright-minds-biosciences
{{cite web |title=Bright Minds Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/bright-minds-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated